IHC staining for CD34 and PAS staining demonstrated enhanced tumor angiogenesis, as evidenced by a higher microvessel density in the HepG2SG group compared to the HepG2-NC group (Figure 7I, **p< 0.01). The gene discussed is CD34; the disease is neoplasm.